Company news
Scribe Therapeutics Inc. news in 2026
Scribe Therapeutics Inc.'s news releases, calls and decks from 2026, newest first.
Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
November 18, 2026
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
November 12, 2026
Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences
November 5, 2026
Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026
November 4, 2026
Decks in 2026
- Investor Presentation (2026)
Investor deck · 31 slides · 2026